Suchergebnisse

The Marine Strategy Framework Directive (MSFD) applies an ecosystem-based model in aspiring to lead EU Member States to the achievement of a Good Environment Status (GES) for eleven different Descriptors of the marine environment. Descriptor 2 of the MSFD focuses on Non-Indigenous Species (NIS), and this study reports the data collected from the Maltese Islands over the 2017-2018 period for this Descriptor. ; N/A

After 2012, inflation has been unexpectedly low across much of the developed world and economists speak of a "missing inflation" puzzle, namely inflation was expected to be higher on the back of an ongoing recovery. This paper investigates the causes and consequences of low inflation in the euro area after 2012 and analyses whether monetary policy has been successful in dampening the risks associated to low inflation. The paper finds that the missing inflation was primarily due to cyclical factors - domestic in the earlier part of the period and global in the latter part - and that the Phillips curve remains a useful tool in understanding inflation dynamics over the period of interest. The succession of negative shocks constrained headline inflation for a prolonged period, and there is evidence of an increase in the persistence of inflation and a fall in the trend inflation rate, which had begun to have a greater influence on longer-term inflation expectations. This may have signalled uncertainty over the effectiveness of unconventional monetary policy measures, but public belief in the ECB's commitment to keep the annual rate of HICP inflation below but close to 2% has remained intact. The paper concludes that unconventional monetary policy measures are effective in mitigating the downside risks to price stability, curtailing risks of de-anchoring, and expanding aggregate demand. ; N/A

A poster presentation regarding biosimilars, drug substance quality issues and their impact on the safety profile of biologics. Introduction: Patent expiry of biologics heralded a new category of medicinal products known as biosimilars, approved on the basis of similarity to their reference products. However, concerns exist among healthcare professionals about the quality and safety of biosimilars compared to their reference products. Aims: • To identify and analyse quality issues encountered during development and manufacture of biosimilars' drug substance; • To determine whether the advent of biosimilars in the EU changed the safety landscape of biologics. ; N/A

Proyecto: La legitimidad de la gobernanza en tiempos de crisis: análisis del funcionamiento del Método Abierto de Coordinación (MAC) en España, Portugal e Italia de 2010 a 2015 (DER2014-53891-P). Financiado por el Ministerio de Economía y Competitividad ; Grupo de investigación: Filosofía del Derecho, Moral y Política. Universitat de Barcelon ; Análisis y evaluación de los diferentes mecanismos de lucha contra la pobreza puestos en marcha en el marco de la Estrategia Europa 2020 a nivel de la UE. ; Financiado por el Ministerio de Economía y Competitividad